Tarceva Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Personalized Medicine Study for Patients With Advanced Cancer of the Breast, Prostate, Pancreas or Those With Refractory Acute Myelogenous Leukemia
Conditions:   Breast Cancer;   Prostate Cancer;   Pancreatic Cancer;   Acute Myelogenous Leukemia Interventions:   Procedure: Biopsy;   Drug: ABIRATERONE;   Drug: ENZALUTAMIDE;   Drug: VENETOCLAX;   Drug: PALBOCICLIB;   Drug: All-trans Retinoic Acid;   Drug: BORTEZOMIB;   Drug: CABAZITAXEL;   Drug: OXALIPLATIN;   Drug: FLUOROURACIL;   Drug: FOLINIC ACID;   Drug: CARBOPLATIN;   Drug : PANOBINOSTAT;   Drug: VORINOSTAT;   Drug: PEMBROLIZUMAB;   Drug: BEVACIZUMAB;   Drug: IPILIMUMAB;   Drug: NIVOLUMAB;   Drug: EVEROLIMUS;   Drug: SIROLIMUS;   Drug: CELECOXIB;   Drug: OLAP...
Source: ClinicalTrials.gov - March 18, 2019 Category: Research Source Type: clinical trials

The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.
(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - November 11, 2018 Category: Cancer & Oncology Source Type: clinical trials